校正:尾切除术和帕金森病的风险:系统性审查和元分析
Hok Leong Chin1, Yiu Sing Tsang2, Haojun Shi2,3
1Section of Neurology, Department of Pediatrics, University of Chicago Medicine, Chicago, IL, United States.
Frontiers in neurology
|February 16, 2026
概括
这项研究纠正了之前的文章DOI. 修改后的国标标识是10.3389/fneur.2025.1619236. 这个数字.
科学领域:
- 神经科学是一个神经科学.
背景情况:
- 纠正之前发表的文章DOI. DOI.
研究的目的:
- 为了提供准确的文章DOI,以便适当引用和引用.
主要方法:
- 数字对象标识符 (DOI) 的行政纠正.
主要成果:
- 该产品的正确DOI现在已经确定为10.3389/fneur.2025.1619236.
结论:
- 确保准确的元数据有助于适当的科学记录和可访问性.
相关概念视频
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K


